Early research (Phase 1)Ended earlyNCT06364696What this trial is testingFind a Suitable Dose of ASP4396 in Adults With Solid TumorsWho this might be right forSolid Tumor Astellas Pharma Inc 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03965689What this trial is testingTesting the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With ImmunotherapyWho this might be right forMetastatic Lung Non-Small Cell Squamous CarcinomaMetastatic Lung Non-Squamous Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8+5 more National Cancer Institute (NCI)
Not applicableStudy completedNCT04670445What this trial is testingImproving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced CancerWho this might be right forStage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more Massachusetts General Hospital 199
Large-scale testing (Phase 3)Ended earlyNCT04866017What this trial is testingCompare Ociperlimab Plus Tislelizumab Versus Durvalumab Following Concurrent Chemoradiotherapy (cCRT) in Participants With Stage III Unresectable Non-Small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer BeiGene 63
Post-approval studies (Phase 4)Study completedNCT00099541What this trial is testingNon-small Cell Lung Cancer RegistryWho this might be right forNon-Small-Cell Lung CancerPleural Effusion, Malignant Novartis Pharmaceuticals 300
Testing effectiveness (Phase 2)Looking for participantsNCT07250477What this trial is testingRisk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Stage IIICNon-small Cell Lung Cancer Stage IVNon Small Cell Lung Cancer+2 more University of California, Davis 56
Testing effectiveness (Phase 2)Looking for participantsNCT05361174What this trial is testingInvestigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung CancerWho this might be right forUnresectable MelanomaMetastatic MelanomaStage III Non-small Cell Lung Cancer+1 more Iovance Biotherapeutics, Inc. 53
Large-scale testing (Phase 3)Active Not RecruitingNCT06472076What this trial is testingBelrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)Who this might be right forLung Cancer, Non-Small Cell GlaxoSmithKline 88
Large-scale testing (Phase 3)Study completedNCT00005838What this trial is testingCombination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By SurgeryWho this might be right forAdenocarcinoma of the LungAdenosquamous Cell Lung CancerLarge Cell Lung Cancer+3 more National Cancer Institute (NCI) 756
Large-scale testing (Phase 3)Active Not RecruitingNCT04380636What this trial is testingStudy of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)Who this might be right forLung NeoplasmsCarcinoma, Non-Small-Cell Lung Merck Sharp & Dohme LLC 870
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07204548What this trial is testingThe IVO-LUNG StudyWho this might be right forNon Small Cell Lung Cancer (Stage III) Sun Yat-sen University 63
Early research (Phase 1)Study completedNCT00019825What this trial is testingDecitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the PleuraWho this might be right forEsophageal CancerLung CancerMalignant Mesothelioma+1 more National Cancer Institute (NCI)
Not applicableStudy completedNCT00900094What this trial is testingUMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With CancerWho this might be right forBreast CancerColorectal CancerEsophageal Cancer+4 more University of Michigan Rogel Cancer Center 200
Large-scale testing (Phase 3)Study completedNCT04303780What this trial is testingStudy to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).Who this might be right forKRAS p, G12c Mutated /Advanced Metastatic NSCLC Amgen 345
Testing effectiveness (Phase 2)Study completedNCT00363766What this trial is testingStudy of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung CancerWho this might be right forNon-Small-Cell Lung Cancer Eli Lilly and Company 52
Testing effectiveness (Phase 2)Looking for participantsNCT06962865What this trial is testingA Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or Recurrent Metastatic NSCLCWho this might be right forNon-Small Cell Lung Cancer RemeGen Co., Ltd. 80
Large-scale testing (Phase 3)UnknownNCT03884192What this trial is testingConsolidation Sintilimab After Concurrent Chemoradiation in Patients With Unresectable Stage III NSCLCWho this might be right forCarcinoma, Non-Small Cell Lung Shandong Cancer Hospital and Institute 162
Testing effectiveness (Phase 2)Looking for participantsNCT06051695What this trial is testingEvaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 ExpressionWho this might be right forSolid Tumor, AdultColorectal CancerNSCLC+17 more A2 Biotherapeutics Inc. 474
Large-scale testing (Phase 3)WithdrawnNCT00055887What this trial is testingChemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung CancerWho this might be right forLung Cancer Spectrum Pharmaceuticals, Inc
Testing effectiveness (Phase 2)Study completedNCT00280787What this trial is testingInduction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With PegfilgrastimWho this might be right forNon Small Cell Lung Cancer UNC Lineberger Comprehensive Cancer Center 24